[Tinidazole in the therapy of anaerobic pulmonary infections].
The purpose of the study in 10 patients with anaerobic lung infections was to demonstrate the efficacy of therapy with Tinidazole. In 9 patients, the clinical evaluation as well as X-ray and bacteriological evidence showed positive results of therapy, while in one patient a mixed anaerobic infection with Streptococcus an., Bacteroides frag., and Clostridium sp. was still present after the end of therapy. Side effects were not observed with Tinidazole therapy.
D001421:Bacteria, Anaerobic / Q000302:isolation & purification*; D004417:Dyspnea / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D009593:Nitroimidazoles / Q000627:therapeutic use*; D011014:Pneumonia / Q000188:drug therapy* / Q000382:microbiology; D013902:Radiography, Thoracic; D013183:Sputum / Q000382:microbiology; D014011:Tinidazole / Q000627:therapeutic use*
D009593:Nitroimidazoles; D014011:Tinidazole
Tinidazol in der Therapie anaerober pulmonaler Infektionen.